06/24/2025 8:06 PM | Carisma Therapeutics Inc. (Subject) Carisma Therapeutics Inc. (Subject) Carisma Therapeutics (Subject)
| Form 425 | |
06/23/2025 4:15 PM | Carisma Therapeutics Inc. (Subject) Carisma Therapeutics Inc. (Subject) Carisma Therapeutics (Subject)
| Form 425 | |
06/23/2025 4:15 PM | Carisma Therapeutics Inc. (Subject) Carisma Therapeutics Inc. (Subject) Carisma Therapeutics (Subject)
| Form 425 | |
06/23/2025 6:41 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/23/2025 6:42 AM | Carisma Therapeutics Inc. (Subject) Carisma Therapeutics Inc. (Subject) Carisma Therapeutics (Subject)
| Form 425 | |
05/13/2025 3:43 PM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
04/16/2025 3:30 PM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/31/2025 3:53 PM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form S-8 Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
03/31/2025 3:32 PM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
01/13/2025 6:00 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
12/09/2024 7:35 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2024 6:35 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
11/07/2024 6:39 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
11/01/2024 3:30 PM | Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics (Issuer) Cheng Sohanya Roshan (Reporting)
| Form 3 Initial statement of beneficial ownership of securities | |
11/01/2024 3:31 PM | Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics Inc. (Issuer) Carisma Therapeutics (Issuer) Cheng Sohanya Roshan (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
10/30/2024 3:30 PM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/11/2024 3:49 PM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
08/08/2024 6:42 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/08/2024 6:37 AM | Carisma Therapeutics Inc. (Filer) Carisma Therapeutics Inc. (Filer) Carisma Therapeutics (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |